EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 100 filers reported holding EPIZYME INC in Q3 2015. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $24,383,000 | +37.8% | 2,015,105 | +12.0% | 0.00% | 0.0% |
| Q3 2016 | $17,699,000 | +2.3% | 1,798,729 | +6.5% | 0.00% | 0.0% |
| Q2 2016 | $17,299,000 | -16.0% | 1,689,314 | -0.5% | 0.00% | -20.0% |
| Q1 2016 | $20,586,000 | +7.5% | 1,698,516 | +42.0% | 0.01% | +25.0% |
| Q4 2015 | $19,158,000 | +16.6% | 1,195,889 | -6.4% | 0.00% | 0.0% |
| Q3 2015 | $16,436,000 | -44.0% | 1,278,065 | +4.5% | 0.00% | -42.9% |
| Q2 2015 | $29,346,000 | +89.4% | 1,222,731 | +48.2% | 0.01% | +75.0% |
| Q1 2015 | $15,495,000 | +12.3% | 825,082 | +12.9% | 0.00% | +33.3% |
| Q4 2014 | $13,795,000 | -26.1% | 731,040 | +6.2% | 0.00% | -40.0% |
| Q3 2014 | $18,666,000 | -11.1% | 688,513 | +2.1% | 0.01% | -16.7% |
| Q2 2014 | $20,995,000 | +62.0% | 674,635 | +18.6% | 0.01% | +50.0% |
| Q1 2014 | $12,958,000 | +32.2% | 569,067 | +20.8% | 0.00% | +33.3% |
| Q4 2013 | $9,799,000 | +61.0% | 471,120 | +209.7% | 0.00% | +50.0% |
| Q3 2013 | $6,086,000 | +61.6% | 152,145 | +13.6% | 0.00% | +100.0% |
| Q2 2013 | $3,767,000 | – | 133,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |